glp-1 drugs depression GLP-1s may alleviate through the microbiome, mouse study suggests GLP-1 drugs tied to lower
Description
November 2023 : Eli Lilly received US FDA approval for ZEPBOUND, an obesity treatment that activates GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors
A synthetic version of one of the peptides found in their venom is used in the painkilling drug ziconotide
& Wong, V
Recent trials suggest these therapies may reduce joint pain, improve physical function, and enhance quality of life in patients with obesity-related osteoarthritis
Endocrinology 136: 35853596
The Terms of Service clarify that described experiences are exceptional and do not reflect the typical outcome
